AI Drug Company Enveda Secures $311 Million to Advance Natural Medicine Clinical Trials

News Summary AI biotechnology company Enveda announced on September 23, 2026 that it has completed a $311 million funding round at a $2 billion valuation. The funds will be used to advance more AI-assisted drugs derived from nature into clinical…



